Cara Care Raises $7M Series A Led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Asabys Partners

Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases.



Latest interview: Network Manager Dr Cora Lüders-Theuerkauf and Strategic Advisor Stefanie Brickwede

Healthcare is one of the most exciting sectors that is expected to fully embrace the development of 3-D printing. Patients and providers alike are looking to a future where the custom fabrication of prostheses, implants, and most likely even whole...


Radiology as a Service: buying clinical imaging instead of devices

Expensive equipment, poor use of capacity: a problem familiar to many healthcare providers. After all, large medical technology devices for MRIs and CTs are costly both to acquire and to maintain. Berlin based company Medneo has been offering a...


Transnational Call - CHEMOPROTEOMICS

Chemoproteomics Call

Under this call EU-OPENSCREEN-DRIVE offers funding to enable transnational access to chemical proteomics and compound disposition study facilities. A total of 6 projects will be selected in two separate calls (scheduled May 2019...



Under this call 12 EU-OPENSCREEN-DRIVE partner institutions will each offer one predefined screening technology to external users. The user will provide the biological question and the related assay matching the offered techniques. The offered...


"Keys to Japan" - Compete for sponsorship of your market entry plan for Japan

Keys to Japan is an European Commission-funded initiative, managed by the EU-Japan Centre. If you are considering marketing a product or service in Japan and you are an SME from an EU Member-State or COSME Third Country, under Keys to Japan, you can...


Emerging Technologies Competition 2019

The Emerging Technologies Competition is the Royal Society of Chemistry’s annual initiative for early stage companies and academic entrepreneurs who want to commercialise their technologies to make a global impact.


Eckert & Ziegler wird in den SDax aufgenommen

Die Berliner Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), ein Spezialist für isotopentechnische Anwendungen in Medizin, Wissenschaft und Industrie, wird mit Wirkung zum 24. Juni 2019 in den SDax aufgenommen. Diese...


Looking beneath the cell surface

BIH scientists have been able to observe receptors transmitting signals inside the cell


The body’s own signaling molecules, and many drugs, often exert their effect via cell surface receptors. These receptors poke through the cell membrane,...

Show more items